logo

Canadian News

Share SHARE

The Japanese yen drifted higher against its major counterparts in the early European session on Thursday. The yen strengthened to more than a 3-week high of 111.70 against the Swiss franc, from a low of 112.40 hit at 9:30 pm ET. The yen rose to 111.02 against the greenback, 138.47 against the pound...

The Canadian dollar strengthened against the other major currencies in the Asian session on Thursday, as crude oil prices advanced after official data showed that gasoline stockpiles continued to fall last week. The crude oil delivery for May is currently up to 0.36 percent or $48.40 per barrel. The...

Pharma-032317.jpg Shares of Ultragenyx Pharmaceutical Inc. (RARE) were down more than 6% in extended trading on Wednesday, following the failure of its phase II UX007 Glucose Transporter Type-1 Deficiency Syndrome seizure study.

The Canadian dollar strengthened against the other major currencies in the Asian session on Thursday. The Canadian dollar rose to an 8-day high of 1.0199 against the Australian dollar and a 2-day high of 1.4366 against the euro, from yesterday's closing quotes of 1.0233 and 1.4390, respectively. Against...

march22-032217.jpg Xenon Pharmaceuticals is all set to report top line data from a phase II trial of XEN801 being developed for the treatment of moderate to severe acne this month.

Canadian stocks nudged higher Wednesday amid bargain hunting after steep recent losses. The S&P/TSX Composite Index rose 35.33 points, or 0.23%, to 15,348.46, improving from multi-month lows. Investors nibbled at energy stocks as crude oil recovered from steep early losses when data showed U.S....

The Canadian stock market is down in early trade Wednesday, extending yesterday's sharp decline. Healthcare stocks are adding to the losses of the previous session and financial stocks are also under pressure. The energy sector is also turning in a weak performance this morning, as crude oil prices...

Canadian stocks may be poised for further weakness Wednesday morning, having wiped out 2017 gains since hitting record highs in February. Energy, financial and some heavyweights in other sectors have been battered of late. Concerns have emerged about U.S.-Canada trade relations, crude oil prices...

The Japanese yen continued to be higher against its most major counterparts in early European deals on Wednesday, with geopolitical worries and uncertainty over the implementation of U.S. President Donald Trump's policy agenda sapping risk sentiment. Investors remained concerned about the fate of...

The Japanese yen drifted higher against its most major counterparts in early European deals on Wednesday. The yen climbed to 111.27 against the greenback, a level unseen since November 2016. The yen rose to a 6-day high of 138.84 against the pound and a 2-week high of 120.22 against euro, from...

Pharma-032217.jpg One more drug has been added in the armamentarium for Parkinson's disease in the U.S., following the FDA approval of Xadago on Tuesday.

Canadian stocks fell sharply Tuesday, extending recent losses as crude oil prices plunged to the lowest since November. Traders remained in a cautious mood despite upbeat economic data for a second day. Canadian retail sales rebounded in January with the largest gain in nearly seven years, Statistics...

The Canadian stock market got off to a positive start Tuesday, but has since trimmed its early gains. The early struggles on Wall Street are having an impact on investor sentiment this morning. Meanwhile, crude oil prices are nearly flat as traders await U.S. inventory data. Healthcare and industrial...

FDA-BVS-032117.jpg It's been a little over eight months since Abbott Vascular Inc.'s fully absorbable stent, Absorb GT1 Bioresorbable Vascular Scaffold, received FDA approval. Abbott Vascluar is a division of Abbott Labs (ABT). Touted as the first and only fully dissolving heart stent approved for the treatment of coronary...

The Canadian dollar firmed against its key counterparts in the European session on Tuesday, as the nation's retail sales growth accelerated more than forecast in January. Data from Statistics Canada showed that retail sales rose a seasonally adjusted 2.2 percent on month to C$46.0 billion in January....

Follow RTT